F. Raja

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Jonathan A. Ledermann, F. Raja, Christina Fotopoulou et al. · Annals of Oncology · 2013 · 1.1K citations · Full text

Medicine, Gynecology, Oncology +14

Optimal first-line treatment in ovarian cancer

F. Raja, Neha Chopra, Jonathan A. Ledermann · Annals of Oncology · 2012 · 154 citations · Full text

Medicine, Gynecology, Oncology +13

Corrections to “Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”

Jonathan A. Ledermann, F. Raja, Christina Fotopoulou et al. · Annals of Oncology · 2018 · 143 citations · Full text

Medicine, Gynecology, Oncology +16

A randomised, placebo-controlled trial of weekly paclitaxel and saracatinib (AZD0530) in platinum-resistant ovarian, fallopian tube or primary peritoneal cancer

Iain A. McNeish, JA Ledermann, Lee Webber et al. · Annals of Oncology · 2014 · 84 citations · Full text

Medicine, Gynecology, Oncology +14

Initial toxicity assessment of ICON6: a randomised trial of cediranib plus chemotherapy in platinum-sensitive relapsed ovarian cancer

F. Raja, Clare Griffin, W. Qian et al. · British Journal of Cancer · 2011 · 62 citations · Full text

Medicine, Oncology, Pharmacology +17